UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 342

Sortiert nach

Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling

Diabetologia, 2009-11, Vol.52 (11), p.2270-2276

Knop, F. K

2009

Link zum Volltext

Verfügbarkeit prüfen

Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies

Diabetologia, 2013-05, Vol.56 (5), p.965-972

2013

Link zum Volltext

Verfügbarkeit prüfen

Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity

Diabetes, obesity & metabolism, 2012-06, Vol.14 (6), p.500-510

2012

Link zum Volltext

Verfügbarkeit prüfen

N‐terminally and C‐terminally truncated forms of glucose‐dependent insulinotropic polypeptide are high‐affinity competitive antagonists of the human GIP receptor

British journal of pharmacology, 2016-03, Vol.173 (5), p.826-838

2016

Link zum Volltext

Verfügbarkeit prüfen

Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes

Diabetologia, 2009-02, Vol.52 (2), p.199-207

2009

Link zum Volltext

Verfügbarkeit prüfen

Species‐specific action of (Pro3)GIP – a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors

British journal of pharmacology, 2016-01, Vol.173 (1), p.27-38

2016

Link zum Volltext

Verfügbarkeit prüfen

Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects

Diabetic medicine, 2013-10, Vol.30 (10), p.1214-1218

2013

Link zum Volltext

Verfügbarkeit prüfen

Regulation of glucagon secretion by incretins

Diabetes, obesity & metabolism, 2011-10, Vol.13 (s1), p.89-94

2011

Link zum Volltext

Verfügbarkeit prüfen

Specificity and sensitivity of commercially available assays for glucagon-like peptide-1 (GLP-1): implications for GLP-1 measurements in clinical studies

Diabetes, obesity & metabolism, 2014-11, Vol.16 (11), p.1155-1164

2014

Link zum Volltext

Verfügbarkeit prüfen

Use of antibiotics in childhood and risk of Type 1 diabetes: a population‐based case–control study

Diabetic medicine, 2017-02, Vol.34 (2), p.272-277

2017

Link zum Volltext

Verfügbarkeit prüfen

Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus

Diabetologia, 2007-04, Vol.50 (4), p.797-805

2007

Link zum Volltext

Verfügbarkeit prüfen

The Pathophysiology of Diabetes Involves a Defective Amplification of the Late-Phase Insulin Response to Glucose by Glucose-Dependent Insulinotropic Polypeptide—Regardless of Etiology and Phenotype

The journal of clinical endocrinology and metabolism, 2003-10, Vol.88 (10), p.4897-4903

2003

Link zum Volltext

Verfügbarkeit prüfen

Reduced Glucose Tolerance and Insulin Resistance Induced by Steroid Treatment, Relative Physical Inactivity, and High-Calorie Diet Impairs the Incretin Effect in Healthy Subjects

The journal of clinical endocrinology and metabolism, 2010-07, Vol.95 (7), p.3309-3317

2010

Link zum Volltext

Verfügbarkeit prüfen

Ghrelin secretion in humans – a role for the vagus nerve?

Neurogastroenterology and motility, 2018-06, Vol.30 (6), p.e13295-n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Decreased plasma chemerin levels in women with gestational diabetes mellitus

Diabetic medicine, 2014-08, Vol.31 (8), p.936-940

2014

Link zum Volltext

Verfügbarkeit prüfen

Management of people with Type 2 diabetes shared between a specialized outpatient clinic and primary health care is noninferior to management in a specialized outpatient clinic: a randomized, noninferiority trial

Diabetic medicine, 2019-07, Vol.36 (7), p.854-861

2019

Link zum Volltext

Verfügbarkeit prüfen

银屑病患者的葡萄糖代谢

British journal of dermatology (1951), 2019-02, Vol.180 (2), p.e54-e54

2019

Link zum Volltext

Verfügbarkeit prüfen

The impact of dipeptidyl peptidase 4 inhibition on incretin effect, glucose tolerance, and gastrointestinal-mediated glucose disposal in healthy subjects

European journal of endocrinology, 2014-09, Vol.171 (3), p.353

2014

Link zum Volltext

Verfügbarkeit prüfen

Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus

Diabetes, obesity & metabolism, 2013-08, Vol.15 (8), p.713-720

2013

Link zum Volltext

Verfügbarkeit prüfen

Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes

Diabetologia, 2008-04, Vol.51 (4), p.632-640

2008

Link zum Volltext

Verfügbarkeit prüfen

Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of the TCF7L2 rs7903146 risk T allele

Diabetes, obesity & metabolism, 2013-01, Vol.15 (1), p.91-95

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of antibiotics on gut microbiota, glucose metabolism and body weight regulation: a review of the literature

Diabetes, obesity & metabolism, 2016-05, Vol.18 (5), p.444-453

2016

Link zum Volltext

Verfügbarkeit prüfen

Glucagon suppression during OGTT worsens while suppression during IVGTT sustains alongside development of glucose intolerance in patients with chronic pancreatitis

Regulatory peptides, 2010-09, Vol.164 (2), p.144-150

2010

Link zum Volltext

Verfügbarkeit prüfen

Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis

Diabetes, obesity & metabolism, 2016-03, Vol.18 (3), p.300-305

2016

Link zum Volltext

Verfügbarkeit prüfen

Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists

International journal of clinical practice (Esher), 2009-08, Vol.63 (8), p.1154-1160

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 342

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(286)
Mit Volltextzugriff
(311)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling

Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies

Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity

N‐terminally and C‐terminally truncated forms of glucose‐dependent insulinotropic polypeptide are high‐affinity competitive antagonists of the human GIP receptor

Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes

Species‐specific action of (Pro3)GIP – a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors

Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects

Regulation of glucagon secretion by incretins

Specificity and sensitivity of commercially available assays for glucagon-like peptide-1 (GLP-1): implications for GLP-1 measurements in clinical studies

Use of antibiotics in childhood and risk of Type 1 diabetes: a population‐based case–control study

Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus

The Pathophysiology of Diabetes Involves a Defective Amplification of the Late-Phase Insulin Response to Glucose by Glucose-Dependent Insulinotropic Polypeptide—Regardless of Etiology and Phenotype

Reduced Glucose Tolerance and Insulin Resistance Induced by Steroid Treatment, Relative Physical Inactivity, and High-Calorie Diet Impairs the Incretin Effect in Healthy Subjects

Ghrelin secretion in humans – a role for the vagus nerve?

Decreased plasma chemerin levels in women with gestational diabetes mellitus

Management of people with Type 2 diabetes shared between a specialized outpatient clinic and primary health care is noninferior to management in a specialized outpatient clinic: a randomized, noninferiority trial

银屑病患者的葡萄糖代谢

The impact of dipeptidyl peptidase 4 inhibition on incretin effect, glucose tolerance, and gastrointestinal-mediated glucose disposal in healthy subjects

Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus

Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes

Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of the TCF7L2 rs7903146 risk T allele

Effect of antibiotics on gut microbiota, glucose metabolism and body weight regulation: a review of the literature

Glucagon suppression during OGTT worsens while suppression during IVGTT sustains alongside development of glucose intolerance in patients with chronic pancreatitis

Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis

Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists

Suchergebnisse filtern